135 related articles for article (PubMed ID: 37608771)
21. Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer.
Sanchez K; Kim I; Chun B; Pucilowska J; Redmond WL; Urba WJ; Martel M; Wu Y; Campbell M; Sun Z; Grunkemeier G; Chang SC; Bernard B; Page DB
Breast Cancer Res; 2021 Jan; 23(1):2. PubMed ID: 33413574
[TBL] [Abstract][Full Text] [Related]
22. Multiplex immunofluorescence staining and image analysis assay for diffuse large B cell lymphoma.
Lee CW; Ren YJ; Marella M; Wang M; Hartke J; Couto SS
J Immunol Methods; 2020 Mar; 478():112714. PubMed ID: 31783023
[TBL] [Abstract][Full Text] [Related]
23. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
[TBL] [Abstract][Full Text] [Related]
24. Automated Quantification of sTIL Density with H&E-Based Digital Image Analysis Has Prognostic Potential in Triple-Negative Breast Cancers.
Thagaard J; Stovgaard ES; Vognsen LG; Hauberg S; Dahl A; Ebstrup T; Doré J; Vincentz RE; Jepsen RK; Roslind A; Kümler I; Nielsen D; Balslev E
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207414
[TBL] [Abstract][Full Text] [Related]
25. Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics.
Sayed S; Koka H; Abubakar M; Gardner K; Salgado R; Moloo Z; Caban-Ureña AB; Rosen D; Castro P; Saleh M; Shaikh AJ; Shah J; Figueroa J; Makokha F; Ha HK; Wang Z; Magangane P; Naidoo R; Ngundo V; Yang XR; Govender D
Breast Cancer Res Treat; 2023 Jun; 199(2):401-413. PubMed ID: 37010652
[TBL] [Abstract][Full Text] [Related]
26. Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy.
Li X; Eastham J; Giltnane JM; Zou W; Zijlstra A; Tabatsky E; Banchereau R; Chang CW; Nabet BY; Patil NS; Molinero L; Chui S; Harryman M; Lau S; Rangell L; Waumans Y; Kockx M; Orlova D; Koeppen H
J Pathol; 2024 Jun; 263(2):190-202. PubMed ID: 38525811
[TBL] [Abstract][Full Text] [Related]
27. Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method.
De Keukeleire SJ; Vermassen T; De Meulenaere A; Deron P; Huvenne W; Duprez F; Creytens D; Van Dorpe J; Rottey S; Ferdinande L
Pathology; 2021 Dec; 53(7):836-843. PubMed ID: 34217516
[TBL] [Abstract][Full Text] [Related]
28. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Roller A; Davydov II; Schwalie PC; Serrano-Serrano ML; Heller A; Staedler N; Ferreira CS; Dietmann G; Klaman I; Valdeolivas A; Korski K; Cannarile MA
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649280
[TBL] [Abstract][Full Text] [Related]
29. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
El Bairi K; Haynes HR; Blackley E; Fineberg S; Shear J; Turner S; de Freitas JR; Sur D; Amendola LC; Gharib M; Kallala A; Arun I; Azmoudeh-Ardalan F; Fujimoto L; Sua LF; Liu SW; Lien HC; Kirtani P; Balancin M; El Attar H; Guleria P; Yang W; Shash E; Chen IC; Bautista V; Do Prado Moura JF; Rapoport BL; Castaneda C; Spengler E; Acosta-Haab G; Frahm I; Sanchez J; Castillo M; Bouchmaa N; Md Zin RR; Shui R; Onyuma T; Yang W; Husain Z; Willard-Gallo K; Coosemans A; Perez EA; Provenzano E; Ericsson PG; Richardet E; Mehrotra R; Sarancone S; Ehinger A; Rimm DL; Bartlett JMS; Viale G; Denkert C; Hida AI; Sotiriou C; Loibl S; Hewitt SM; Badve S; Symmans WF; Kim RS; Pruneri G; Goel S; Francis PA; Inurrigarro G; Yamaguchi R; Garcia-Rivello H; Horlings H; Afqir S; Salgado R; Adams S; Kok M; Dieci MV; Michiels S; Demaria S; Loi S;
NPJ Breast Cancer; 2021 Dec; 7(1):150. PubMed ID: 34853355
[TBL] [Abstract][Full Text] [Related]
30. [Standardized determination of tumor-infiltrating lymphocytes in breast cancer : A prognostic marker for histological diagnosis].
Denkert C; Loibl S; Budczies J; Wienert S; Klauschen F
Pathologe; 2018 Nov; 39(6):520-531. PubMed ID: 30327858
[TBL] [Abstract][Full Text] [Related]
31. Programmed death ligand 1 (PD-L1) in colon cancer and its interaction with budding and tumor-infiltrating lymphocytes (TILs) as tumor-host antagonists.
Lang-Schwarz C; Melcher B; Hartmann A; Bertz S; Dregelies T; Lang-Schwarz K; Vieth M; Sterlacci W
Int J Colorectal Dis; 2021 Nov; 36(11):2497-2510. PubMed ID: 34170390
[TBL] [Abstract][Full Text] [Related]
32. Deep-Learning-Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics Data.
Lu Z; Xu S; Shao W; Wu Y; Zhang J; Han Z; Feng Q; Huang K
JCO Clin Cancer Inform; 2020 May; 4():480-490. PubMed ID: 32453636
[TBL] [Abstract][Full Text] [Related]
33. The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
Gonzalez-Ericsson PI; Stovgaard ES; Sua LF; Reisenbichler E; Kos Z; Carter JM; Michiels S; Le Quesne J; Nielsen TO; Laenkholm AV; Fox SB; Adam J; Bartlett JM; Rimm DL; Quinn C; Peeters D; Dieci MV; Vincent-Salomon A; Cree I; Hida AI; Balko JM; Haynes HR; Frahm I; Acosta-Haab G; Balancin M; Bellolio E; Yang W; Kirtani P; Sugie T; Ehinger A; Castaneda CA; Kok M; McArthur H; Siziopikou K; Badve S; Fineberg S; Gown A; Viale G; Schnitt SJ; Pruneri G; Penault-Llorca F; Hewitt S; Thompson EA; Allison KH; Symmans WF; Bellizzi AM; Brogi E; Moore DA; Larsimont D; Dillon DA; Lazar A; Lien H; Goetz MP; Broeckx G; El Bairi K; Harbeck N; Cimino-Mathews A; Sotiriou C; Adams S; Liu SW; Loibl S; Chen IC; Lakhani SR; Juco JW; Denkert C; Blackley EF; Demaria S; Leon-Ferre R; Gluz O; Zardavas D; Emancipator K; Ely S; Loi S; Salgado R; Sanders M;
J Pathol; 2020 Apr; 250(5):667-684. PubMed ID: 32129476
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
[TBL] [Abstract][Full Text] [Related]
35. Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells.
Gonzàlez-Farré M; Gibert J; Santiago-Díaz P; Menéndez S; Monzonis X; Olivares F; Riera X; López D; Torner A; Casado B; Bellosillo B; Lloveras B; Casadevall D; Rovira A; Servitja S; Albanell J; Vázquez I; Comerma L
Hum Pathol; 2023 Sep; 139():91-105. PubMed ID: 37517596
[TBL] [Abstract][Full Text] [Related]
36. Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies.
Castaneda CA; Castillo M; Aliaga K; Bernabe LA; Casavilca S; Sanchez J; Torres-Cabala CA; Gomez HL; Mas L; Dunstan J; Cotrina JM; Abugattas J; Chavez I; Ruiz E; Montenegro P; Rojas V; Orrego E; Galvez-Nino M; Felix B; Landa-Baella MP; Vidaurre T; Villa MR; Zevallos R; Taxa L; Guerra H
Biomark Med; 2019 Dec; 13(17):1481-1491. PubMed ID: 31621387
[No Abstract] [Full Text] [Related]
37. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL
Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
39. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
Ahuja S; Khan AA; Zaheer S; Ranga S
Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
[TBL] [Abstract][Full Text] [Related]
40. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
